Abstract
A surface-enhanced Raman scattering(SERS) sensing approach for urine glucose was developed based on the laminar flow technology in a cross-type microfluidic chip with SERS probes, 4-mercaptophenylboronic acid (MPBA) functionalized Ag nanoparticles. MPBA as the glucose receptor can identify and bind up with glucose at a molar ratio of 2:1, which can cause the aggregation of SERS probes at a certain position of the chip channel and further enhance the SERS signal of MPBA significantly. Thus, the quantitative SERS detection of glucose was achieved indirectly. No sample pretreatment and separation were needed in this method since the SERS detection was achieved in the gradient diffusion and molecular recognition processes between urine glucose and SERS probe in the laminar flow, which simplified the sample treatment procedures, saved detection time and made it feasible for clinic applications. This method shows a good linear relationship within human body’s normal physiological range and has high sensitivity and selectivity. The lowest detection concentration can reach 1.0 mg/dL.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
